Corium Pharma Solutions, Inc. - Nov. 18, 2022
Nov 18, 2022
Daniel A. Arsulowicz
Chief Operating Officer
4558 50th St. SE
Nov 14, 2022 - Nov 18, 2022
Investigator(s): Brent M. Dehaan, Amanda M. Dunneback, and Joseph Piechocki
Control procedures are not established which validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product.